recombinant human pro hgf (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
95
Structured Review
R&D Systems
recombinant human pro hgf
Recombinant Human Pro Hgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 308 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+pro+hgf/Recombinant+Human+HGF+Protein/pmc12024841-39-0-6
Average 95 stars, based on 308 article reviews
Recombinant Human Pro Hgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 308 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+pro+hgf/Recombinant+Human+HGF+Protein/pmc12024841-39-0-6
Average 95 stars, based on 308 article reviews
recombinant human pro hgf - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Recombinant:Article Title: Phosphorylation of MET Is Upregulated in Metastatic Sites of Renal Cell Carcinoma: Possible Role of MET and Hepatocyte Growth Factor Activation-Targeted Combined Therapy. Article Snippet: An antibody against c-MET (Y1235 phosphorylated) purchased from ImmunoBiological Laboratories (Gunma, Japan), an antibody against Met purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), and an antibody against CD10 purchased from Leica Biosystems (Nussloch, Germany) were used for immunohistochemistry. .. Article Title: Possible role of combined therapy targeting MET and pro-HGF activation for renal cell carcinoma: analysis by human HGF-producing SCID mice. Article Snippet: MET is a high-affinity receptor tyrosine kinase of HGF (hepatocyte growth factor).. HGF is secreted as an inactive singlechain precursor (pro-HGF), which requires proteolytic activation for conversion to an active form.. HGF activator inhibitor (HAI)-2 is a transmembrane Kunitz-type serine protease inhibitor, which inhibits all pro-HGF-activating enzymes. Article Title: Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors Article Snippet: Recombinant human pro-HGF (75 ng, R&D Systems) was added, and the samples were incubated for 4.5 h at 37 °C before the addition of reducing loading dye (including 200 m m DTT). .. Article Title: Phosphorylation of MET Is Upregulated in Metastatic Sites of Renal Cell Carcinoma: Possible Role of MET and Hepatocyte Growth Factor Activation-Targeted Combined Therapy Article Snippet: An antibody against c-MET (Y1235 phosphorylated) purchased from Immuno-Biological Laboratories (Gunma, Japan), an antibody against Met purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), and an antibody against CD10 purchased from Leica Biosystems (Nussloch, Germany) were used for immunohistochemistry. .. Article Title: Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2 Article Snippet: Recombinant mouse myeloma cell line, NS0-derived His-tagged human HAI-2 (A28-K197) was purchased from R&D Systems (cat. no. 1106-PI). .. other:Article Title: A Short Isoform of Coagulation Factor XII mRNA Is Expressed by Neurons in the Human Brain. Article Snippet: T E D P R O O F Abstract—Coagulation factor XII (FXII) is synthesized in the liver and secreted into the circulation, where it initiates the contact activation system.. Although typically thought to be restricted to the circulation, FXII protein has been found in the brain of Alzheimer's disease (AD) andmultiple sclerosis patients.. Moreover, activation of the contact system has been detected in the cerebrospinal fluid of these patients as well as in the brain of healthy and AD individuals. Article Title: Non-human animals comprising a humanized coagulation factor 12 locus Article Snippet: SDS-PAGE was performed using 4-20% Tris-Glycine gels (Invitrogen), the gels transferred onto 0.2 μm PVDF membranes (BioRad; Hercules, Calif.), and analyzed with antibodies against mouse factor XII (CloudClone Corp; Katy, Tex. Incubation:Article Title: Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors Article Snippet: Recombinant human pro-HGF (75 ng, R&D Systems) was added, and the samples were incubated for 4.5 h at 37 °C before the addition of reducing loading dye (including 200 m m DTT). .. |